Aliases & Classifications for Dysphagia

Aliases & Descriptions for Dysphagia:

Name: Dysphagia 51 29 52
Deglutition Disorders 69

Classifications:



External Ids:

ICD10 33 R13

Summaries for Dysphagia

NINDS : 51 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Dysphagia, also known as deglutition disorders, is related to myopathy, areflexia, respiratory distress, and dysphagia, early-onset and dysphagia lusoria, and has symptoms including abdominal pain, constipation and diarrhea. An important gene associated with Dysphagia is MEGF10 (Multiple EGF Like Domains 10). The drugs Dopamine and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and tongue, and related phenotype is Increased shRNA abundance (Z-score > 2).

Wikipedia : 71 Dysphagia is the medical term for the symptom of difficulty in swallowing. Although classified under... more...

Related Diseases for Dysphagia

Diseases related to Dysphagia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 283)
id Related Disease Score Top Affiliating Genes
1 myopathy, areflexia, respiratory distress, and dysphagia, early-onset 12.2
2 dysphagia lusoria 12.2
3 odontoma-dysphagia syndrome 12.2
4 plummer vinson syndrome 11.8
5 swallowing disorders 11.3
6 oculopharyngeal muscular dystrophy 11.2
7 opitz-gbbb syndrome 11.0
8 aspiration pneumonia 11.0
9 esophageal tuberculosis 11.0
10 aberrant subclavian artery 10.9
11 myasthenia gravis 10.9
12 opitz gbbb syndrome, type ii 10.8
13 chromosome 1p36 deletion syndrome 10.7
14 chiari malformation type ii 10.7
15 neurodegeneration with brain iron accumulation 3 10.7
16 chronic progressive external ophthalmoplegia 10.7
17 central pontine myelinolysis 10.7
18 thiamine metabolism dysfunction syndrome 2 10.7
19 primary familial brain calcification 10.6
20 achalasia, familial esophageal 10.6
21 esophagitis, eosinophilic, 1 10.6
22 neurodegeneration with brain iron accumulation 4 10.6
23 capos syndrome 10.6
24 striatonigral degeneration, infantile 10.6
25 diffuse cutaneous systemic sclerosis 10.6
26 peroxisome biogenesis disorder 8b 10.6
27 thyroid cancer, anaplastic 10.6
28 fazio-londe disease 10.6
29 spastic paralysis, infantile onset ascending 10.6
30 amyotrophic lateral sclerosis 1 10.6
31 thyroglossal duct cyst, familial 10.6
32 leigh syndrome 10.6
33 wilson disease 10.6
34 oculopharyngodistal myopathy 10.6
35 scapuloperoneal syndrome, neurogenic, kaeser type 10.6
36 spinal and bulbar muscular atrophy of kennedy 10.6
37 leber hereditary optic neuropathy with dystonia 10.6
38 mohr-tranebjaerg syndrome 10.6
39 laryngeal tuberculosis 10.6
40 colonic pseudo-obstruction 10.6
41 biotin-thiamine-responsive basal ganglia disease 10.6
42 spinocerebellar ataxia 7 10.6
43 pontocerebellar hypoplasia, type 2e 10.6
44 intestinal pseudo-obstruction 10.6
45 esophagitis 10.3
46 cervicitis 10.3
47 hyperostosis 10.2
48 diffuse idiopathic skeletal hyperostosis 10.2
49 pneumonia 10.1
50 muscular dystrophy 10.0

Graphical network of the top 20 diseases related to Dysphagia:



Diseases related to Dysphagia

Symptoms & Phenotypes for Dysphagia

UMLS symptoms related to Dysphagia:


abdominal pain, constipation, diarrhea, dyspepsia, flatulence, eructation, and gas pain, headache, heartburn, icterus, nausea, nausea and vomiting, pain, seizures, signs and symptoms, digestive, vomiting, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, digestive system symptom, choking sensation, gastrointestinal gas, symptom as reason for upper g.i. examination, pseudobulbar signs, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase

GenomeRNAi Phenotypes related to Dysphagia according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 9.32 MID1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-108 9.32 MID1
3 Increased shRNA abundance (Z-score > 2) GR00366-A-128 9.32 MID1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-168 9.32 SLC19A3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.32 MID1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-23 9.32 MID1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-3 9.32 MID1 SLC19A3
8 Increased shRNA abundance (Z-score > 2) GR00366-A-31 9.32 SLC19A3
9 Increased shRNA abundance (Z-score > 2) GR00366-A-46 9.32 SLC19A3
10 Decreased ionizing radiation sensitivity GR00232-A-1 9.26 DES MID1 PABPN1 PIK3C2A

Drugs & Therapeutics for Dysphagia

Drugs for Dysphagia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 584)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 3,Phase 1 51-61-6, 62-31-7 681
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 50-02-2 5743
3
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
4
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1 102625-70-7 4679
5
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
6
Acetaminophen Approved Phase 4 103-90-2 1983
7
Acetylcholine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-84-3 187
8
Olanzapine Approved, Investigational Phase 4,Phase 2,Phase 3 132539-06-1 4585
9
Budesonide Approved Phase 4,Phase 2,Phase 3 51333-22-3 63006 5281004
10
Cetuximab Approved Phase 4,Phase 3,Phase 2,Phase 1 205923-56-4 56842117 2333
11
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2 2180-92-9, 38396-39-3 2474
12
Sucralfate Approved Phase 4,Phase 3 54182-58-0
13
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 103577-45-3 3883
14
Rabeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 117976-89-3 5029
15
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 161796-78-7, 119141-88-7 4594 9579578
16
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3 57808-66-9 3151
17
Menthol Approved Phase 4,Phase 1,Phase 2 2216-51-5 16666
18
Ethanol Approved Phase 4,Phase 1,Phase 2,Early Phase 1 64-17-5 702
19
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
20
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
21
Morphine Approved, Investigational Phase 4 57-27-2 5288826
22
Cimetidine Approved Phase 4 51481-61-9 2756
23
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
24
Metoclopramide Approved, Investigational Phase 4,Phase 3,Phase 1 364-62-5 4168
25
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 75614-87-8, 51-45-6 774
26
Ranitidine Approved Phase 4,Phase 3,Phase 2 66357-59-3, 66357-35-5 3001055
27
Naloxone Approved, Vet_approved Phase 4,Phase 1,Phase 2 465-65-6 5284596
28
Famotidine Approved Phase 4,Phase 2,Phase 3 76824-35-6 3325
29
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
30
Isoflurane Approved, Vet_approved Phase 4,Phase 1,Phase 2 26675-46-7 3763
31
Sevoflurane Approved, Vet_approved Phase 4,Phase 1,Phase 2 28523-86-6 5206
32
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2 137-58-6 3676
33
Remifentanil Approved Phase 4,Phase 3 132875-61-7 60815
34
Meloxicam Approved, Vet_approved Phase 4,Phase 2 71125-38-7 5281106 54677470
35
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
36
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
37
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
38
Nortriptyline Approved Phase 4,Phase 2,Phase 3 72-69-5 4543
39
Nizatidine Approved Phase 4,Phase 3 76963-41-2 3033637
40
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
41
Methylnaltrexone Approved Phase 4 83387-25-1, 916055-93-1 6603824
42
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
43
Desflurane Approved Phase 4,Phase 1,Phase 2 57041-67-5 42113
44
Nystatin Approved, Vet_approved Phase 4,Phase 3 1400-61-9 11953884
45
Levobupivacaine Approved Phase 4 27262-47-1 92253
46
Aluminum hydroxide Approved Phase 4,Phase 3,Phase 2,Phase 1 21645-51-2
47
Magnesium Hydroxide Approved Phase 4,Phase 3,Phase 2,Phase 1 1309-42-8
48 Magnesium trisilicate Approved Phase 4,Phase 3,Phase 1 14987-04-3
49
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-24-8 5755
50 Trimebutine Approved Phase 4 39133-31-8

Interventional clinical trials:

(show top 50) (show all 1434)
id Name Status NCT ID Phase
1 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Unknown status NCT01507207 Phase 4
2 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
3 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
4 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4
5 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
6 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
7 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4
8 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4
9 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4
10 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4
11 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis Unknown status NCT01846962 Phase 4
12 EXPAREL® for Pain After Tonsillectomy Unknown status NCT02444533 Phase 4
13 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
14 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4
15 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
16 Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia Completed NCT01081444 Phase 4
17 Dysphagia in Elderly Medical Patients Completed NCT01006330 Phase 4
18 Acetaminophen's Efficacy For Post-operative Pain Completed NCT01721486 Phase 4
19 Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain Completed NCT02322346 Phase 4
20 Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers Completed NCT01924234 Phase 4
21 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Completed NCT00528541 Phase 4
22 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4
23 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4
24 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
25 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
26 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4
27 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
28 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) Completed NCT00872755 Phase 4
29 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Completed NCT00641602 Phase 4
30 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4
31 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4
32 The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series Completed NCT02106273 Phase 4
33 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4
34 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4
35 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
36 Role of Mosapride in Patients With Gastroesophageal Reflux Disease Completed NCT00729339 Phase 4
37 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4
38 Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00625495 Phase 4
39 Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US Completed NCT00660660 Phase 4
40 A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) Completed NCT00734097 Phase 4
41 An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Dise Completed NCT00629564 Phase 4
42 Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. Completed NCT01601379 Phase 4
43 Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) Completed NCT00246909 Phase 4
44 Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv Completed NCT00626262 Phase 4
45 Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) Completed NCT00261339 Phase 4
46 Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B Completed NCT03128736 Phase 4
47 PPI Sequencing Study Completed NCT00384592 Phase 4
48 Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients Completed NCT00574925 Phase 4
49 Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously Completed NCT00635414 Phase 4
50 CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing Completed NCT00354757 Phase 4

Search NIH Clinical Center for Dysphagia

Genetic Tests for Dysphagia

Genetic tests related to Dysphagia:

id Genetic test Affiliating Genes
1 Dysphagia 29

Anatomical Context for Dysphagia

MalaCards organs/tissues related to Dysphagia:

39
Brain, Testes, Tongue, Thyroid, Heart, Colon, Lung

Publications for Dysphagia

Articles related to Dysphagia:

(show top 50) (show all 1026)
id Title Authors Year
1
Dysphagia in Friedreich Ataxia. ( 28474131 )
2017
2
Pulmonary hyalinizing granuloma presenting with dysphagia: a rare presentation. ( 27940652 )
2017
3
Lymphocytic esophagitis: A rare finding in adult patients with dysphagia and food impaction. ( 28089355 )
2017
4
A rare association of dysphagia and cervical compressive myelopathy in diffuse idiopathic skeletal hyperostosis. ( 28084279 )
2017
5
"Dysphagia-Related Quality of Life in Oculopharyngeal Muscular Dystrophy: Psychometric Properties of the SWAL-QOL Instrument. ( 28472864 )
2017
6
Giant Thoracic Aortic Aneurysm Manifested as Dysphagia and Dyspnea. ( 28007285 )
2017
7
Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the Swallow Response in Patients with Oropharyngeal Dysphagia: White Paper by the European Society for Swallowing Disorders (ESSD). ( 27016216 )
2016
8
Dysphagia Management and Research in an Acute-Care Military Treatment Facility: The Role of Applied Informatics. ( 27168564 )
2016
9
Dyskeratosis congenita presenting with dysphagia. ( 27559501 )
2016
10
Looking into oropharyngeal dysphagia in older adults. ( 27144326 )
2016
11
Diagnosis and evaluation of 100 dysphagia patients using videoendoscopy at a core hospital of a local city in Japan. ( 27167386 )
2016
12
Eosinophilic Esophagitis in Children and Adolescents with Abdominal Pain: Comparison with EoE-Dysphagia and Functional Abdominal Pain. ( 27610357 )
2016
13
An unusual cause of dysphagia: Isolated IgG 4-related esophageal disease. ( 28000632 )
2016
14
Dysphagia, dystussia, and aspiration pneumonia in elderly people. ( 27076964 )
2016
15
Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia. ( 27098244 )
2016
16
Dysphagia due to Esophageal Duplication Cyst. ( 27574754 )
2016
17
Lujan-Fryns Syndrome (LFS): A Unique Combination of Hypernasality, Marfanoid Body Habitus, and Neuropsychiatric Issues, Presenting as Acute-Onset Dysphagia. ( 27980443 )
2016
18
Assessment of Oropharyngeal Dysphagia in Patients With Parkinson Disease: Use of Ultrasonography. ( 27152267 )
2016
19
Dysphagia-Related Quality of Life in Oculopharyngeal Muscular Dystrophy: Psychometric Properties of the SWAL-QOL Instrument. ( 27759888 )
2016
20
Effect of Vocal Fold Medialization on Dysphagia in Patients with Unilateral Vocal Fold Immobility. ( 27165683 )
2016
21
A review of postsurgical dysphagia in nonmalignant disease. ( 27636981 )
2016
22
A single-subject study to evaluate the inhibitory repetitive transcranial magnetic stimulation combined with traditional dysphagia therapy in patients with post-stroke dysphagia. ( 27648175 )
2016
23
Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature. ( 27722170 )
2016
24
Hybrid treatment of dysphagia lusoria: right carotid to subclavian bypass and endovascular insertion of an Amplatzer II Vascular Plug. ( 26901624 )
2016
25
Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies. ( 27167831 )
2016
26
Neuromuscular Electrical Stimulation for Treatment-Refractory Chronic Dysphagia in Tube-Fed Patients: A Prospective Case Series. ( 27160206 )
2016
27
Accuracy of clinical swallowing evaluation for diagnosis of dysphagia in children with laryngomalacia or glossoptosis. ( 27228428 )
2016
28
Bilateral vocal fold paralysis and dysphagia secondary to diffuse idiopathic skeletal hyperostosis. ( 27557480 )
2016
29
Evaluation of a dysphagia screening system based on the Mann Assessment of Swallowing Ability for use in dependent older adults. ( 27195778 )
2016
30
Clinical application of ICF key codes to evaluate patients with dysphagia following stroke. ( 27661012 )
2016
31
Histopathological study of upper gastrointestinal endoscopic biopsy in patients with dysphagia and dyspepsia in south western coast of India. ( 27772904 )
2016
32
Expanding Instrumental Options for Dysphagia Diagnosis and Research: Ultrasound and Manometry. ( 27160285 )
2016
33
Traumatic aortic aneurysm diagnosed by computed tomography angiography in a 22-year-old man presenting with progressive dyspnea and dysphagia. ( 27209281 )
2016
34
Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure. ( 27898735 )
2016
35
Noninvasive brain stimulation for dysphagia after acquired brain injury: a systematic review. ( 27644550 )
2016
36
The Functional Dysphagia Scale Is a Useful Tool for Predicting Aspiration Pneumonia in Patients With Parkinson Disease. ( 27446780 )
2016
37
Intraoral excision of a huge retropharyngeal lipoma causing dysphagia and obstructive sleep apnea. ( 27939855 )
2016
38
Epidermolysis bullosa acquisita associated with dysphagia and stricture of esophagus. ( 27643544 )
2016
39
Erratum to: Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the Swallow Response in Patients with Oropharyngeal Dysphagia: White Paper by the European Society for Swallowing Disorders (ESSD). ( 27444733 )
2016
40
A 34-year-old man with refractory heartburn and intermittent dysphagia to solids. ( 27141037 )
2016
41
An Unusual Cause of Dysphagia and Melena. ( 27593910 )
2016
42
Congenital Esophageal Duplication Cyst: A Rare Cause of Dysphagia in an Adult. ( 27785331 )
2016
43
Implementing oral care to reduce aspiration pneumonia amongst patients with dysphagia in a South African setting. ( 26974243 )
2016
44
Therapeutic intervention in oropharyngeal dysphagia. ( 27625188 )
2016
45
Huge Parathyroid Adenoma with Dysphagia Presentation; A Case Report from Southern Iran. ( 27582595 )
2016
46
Coincidence of Eagle Syndrome and Diffuse Idiopathic Skeletal Hyperostosis Presenting With Dysphagia as a Result of Compression of the Hypopharynx. ( 28027183 )
2016
47
Dysphagia in Tongue Cancer Patients Before and After Surgery. ( 27126392 )
2016
48
Dysphagia Lusoria: An Unexpected Sequelum of Cardiothoracic Surgery. ( 26874690 )
2016
49
Hirsute Esophagus: An Unusual Cause of Dysphagia. ( 27634180 )
2016
50
Erratum to: Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia. ( 27889862 )
2016

Variations for Dysphagia

Expression for Dysphagia

Search GEO for disease gene expression data for Dysphagia.

Pathways for Dysphagia

GO Terms for Dysphagia

Biological processes related to Dysphagia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 muscle contraction GO:0006936 8.62 DES PABPN1

Sources for Dysphagia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....